ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting.

H T van der Galiën et al.PubMed ↗Publisher ↗

No numbers read from the abstract.